Reuters logo
BRIEF-Midazolam Nasal Spray met main goal of a late-stage trial in patients with seizure clusters
April 26, 2017 / 10:11 PM / 5 months ago

BRIEF-Midazolam Nasal Spray met main goal of a late-stage trial in patients with seizure clusters

April 26 (Reuters) -

* Midazolam nasal spray (usl261) phase 3 trial meets primary efficacy endpoint in patients with seizure clusters Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below